Back to search results

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Abroad (travel likely)RecruitingPHASE3

Conditions

Turner Syndrome · Short Stature Homeobox Gene Mutation · Idiopathic Short Stature · Small for Gestational Age at Delivery

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ascendis Pharma Investigational Site, Palo Alto, California, United States

  • Ascendis Pharma Investigational Site, Sacramento, California, United States

  • Ascendis Pharma Investigational Site, Aurora, Colorado, United States

  • Ascendis Pharma Investigational Site, Centennial, Colorado, United States

  • Ascendis Pharma Investigational Site, Orlando, Florida, United States

  • Ascendis Pharma Investigational Site, St. Petersburg, Florida, United States

  • Ascendis Pharma Investigational Site, Atlanta, Georgia, United States

  • Ascendis Pharma Investigational Site, Idaho Falls, Idaho, United States

  • Ascendis Pharma Investigational Site, New Orleans, Louisiana, United States

  • Ascendis Pharma Investigational Site, Minneapolis, Minnesota, United States

  • Ascendis Pharma Investigational Site, Saint Paul, Minnesota, United States

  • Ascendis Pharma Investigational Site, Lake Success, New York, United States

  • Ascendis Pharma Investigational Site, Oklahoma City, Oklahoma, United States

  • Ascendis Pharma Investigational Site, Edinburg, Texas, United States

  • Ascendis Pharma Investigational Site, Fort Worth, Texas, United States

  • Ascendis Pharma Investigational Site, San Antonio, Texas, United States

  • Ascendis Pharma Investigational Site, San Antonio, Texas, United States

  • Ascendis PharmaInvestigational Site, Le Kremlin-Bicêtre, France

  • Ascendis Pharma Investigational Site, Toulouse, France

  • Ascendis Pharma Investigational Site, Hanover, Germany

  • Ascendis Pharma Investigational Site, Naples, Italy

  • Ascendis Pharma Investigational Site, Sejong, South Korea

  • Ascendis Pharma Investigational Site, Seoul, South Korea

  • Ascendis Pharma Investigational Site, Seoul, South Korea

  • Ascendis Pharma Investigational Site, Seoul, South Korea

  • Ascendis Pharma Investigational Site, Seoul, South Korea

  • Ascendis Pharma Investigational Site, Barcelona, Spain

  • Ascendis Pharma Investigational Site, Madrid, Spain

  • Ascendis Pharma Investigational Site, Málaga, Spain

  • Ascendis Pharma Investigational Site, Zaragoza, Spain

Study leads

  • Medical Director, MD

    Study Director

    Ascendis Pharma A/S

View source on ClinicalTrials.gov(opens in a new tab)